HC Deb 05 February 1990 vol 166 c484W
Mr. Martyn Jones

To ask the Secretary of State for Health whether he has any plans to halt the increase in drug promotion by companies.

Mrs. Virginia Bottomley

Expenditure on promotion by pharmaceutical companies supplying the NHS with drugs within the terms of the pharmaceutical price regulation scheme is limited by that scheme. For the companies in aggregate it is limited to 9 per cent, of sales revenue.